Latest filing published 27 May 2022 for IonQ, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Blake Byers: trading record in brief
This profile gathers the share dealings of Blake Byers across 2 companies, led by IonQ, Inc. and Dianthus Therapeutics, Inc. /DE/. Over a trading history stretching from 25 June 2018 to 26 May 2022, the count stands at 6 filings.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 27 May 2022: a share grant, in IonQ, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Blake Byers
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 16,210 shares0Common StockSEC:0001209191-22-032655:0
- 125,967 shares0Common StockSEC:0001209191-22-025453:0
- 125,967 shares0Common StockSEC:0001209191-22-024325:0
- 3,750 shares0Common StockSEC:0001209191-22-003797:0
- 300,000 shares@ US$10.00100.0% of flowCommon StockSEC:0001209191-21-059175:0
5 of 5 declarations
